The Oxford Nanopore MinION represents a portable, real-time sequencing device that produces ultra-long reads from individual DNA and RNA molecules without the need for PCR amplification. Each MinION ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent ...

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) just unveiled an update. Oxford Nanopore Technologies PLC announced a transaction involving its ...

OXFORD, England, April 14, 2025--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners ...

Oxford Nanopore sequencing overcomes these challenges, providing scientists and public health officials with a comprehensive, rapid, and cost-effective pathogen surveillance approach. Lab safety rules ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases The two companies have completed a ...

Shares in genomics sequencing company Oxford Nanopore were rising sharply this morning after it announced an £80 million ($102 million) share placement that included a £50 million investment ...

The Asuragen kit business continues to gain strong momentum. Asuragen’s recent partnership with Oxford Nanopore Technologies accurately delivers an ideal solution for labs looking to provide ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent noise of acquisition vulnerability. The UK biotech, a former star of ...

LONDON - Oxford Nanopore Technologies plc disclosed Monday that its Chief Financial Officer, Nick Keher, has been granted shares under the company’s Share Incentive Plan (SIP). The transaction ...